Some Winners Emerge Despite China’s Reimbursement Price-Cutting Scheme

Higher Volumes Benefit Selected PD-1s

 
• By Dexter Jie Yan
winners from China NRDL scheme
BeiGene and Innovent appear to take lead in revenue growth • Source: Alamy

More from China

More from Focus On Asia